Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.
Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.
复制标题
DOI:
10.1016/j.biomaterials.2013.01.032
复制
发表时间:
2013-04
期刊:
影响因子:
14
通讯作者:
Keselowsky, Benjamin G.
中科院分区:
文献类型:
--
作者:
Acharya, Abhinav P.;Lewis, Jamal S.;Keselowsky, Benjamin G.
There is a great interest for developing poly(lactide-co-glycolide) (PLGA) based particles for targeted delivery and controlled release of encapsulated biological molecules. The PLGA particles can be used to deliver proteins, small molecule drugs and nucleotides. Furthermore, it has been shown that the co-encapsulation of multiple factors in PLGA particles generates synergistic responses, and can simultaneously provide theranostic benefits. However, the number of possible unique particle formulations that may be generated by the combination of different components in a particle increases dramatically with each new component, and currently, there is no method to generate such a vast library of unique PLGA particles. In order to address this gap, we have developed a high-throughput methodology to produce hundreds of small batches of particles. The particles are generated in the multi-well plate wells by a modified oil-in-water emulsion technique. In order to demonstrate the versatility of this technique, combinatorial formulations of six different loading concentrations of three fluorescent dyes were fabricated giving rise to 216 unique PLGA particle formulations. We demonstrate systematic and well-controlled combinatorial loading of hydrophobic molecules into the particles. This PPP methodology potentiates the generation of hundreds of different combinatorial particle formulations with multiple co-encapsulates in less than 24 h in standard polystyrene multi-well plates, thus providing rapid, low cost, high-throughput production. We envision that such a PPP library of particles encapsulating combinations of drugs and imaging modalities can subsequently be tested on small populations of cells in a high-throughput fashion, and provide personalized medicine.
登录
查看更多内容
DOI:
10.1016/j.jconrel.2010.05.032
发表时间:
2010-09-15
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Norton LW;Park J;Babensee JE
通讯作者:
Babensee JE
影响因子:
9.7
作者:
Acharya, Abhinav P.;Dolgova, Natalia V.;Keselowsky, Benjamin G.
通讯作者:
Keselowsky, Benjamin G.
影响因子:
14
作者:
Acharya, Abhinav P.;Clare-Salzler, Michael J.;Keselowsky, Benjamin G.
通讯作者:
Keselowsky, Benjamin G.
影响因子:
10.8
作者:
Diwan, M;Tafaghodi, M;Samuel, J
通讯作者:
Samuel, J
影响因子:
5.1
作者:
Lü JM;Wang X;Marin-Muller C;Wang H;Lin PH;Yao Q;Chen C
通讯作者:
Chen C